Neurologic treatment strategies in autism: An overview of medical intervention strategies

Seminars in Pediatric Neurology

Volumn 11, Issue 3, 2004, Pages 229-235

  Chez, Michael G ^a,b   Memon, Shoaib ^a   Hung, Paul C ^a  

^a IL   (United States)

^b Libertyville IL 60048 ^*  (United States)

Author keywords

alternative therapies; autism treatment; behavioral disorder; cholinergic; glutamate; language disorder

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CARNOSINE; CLONIDINE; DIPEPTIDE DERIVATIVE; DONEPEZIL; DOPAMINE; ESCITALOPRAM; ETIRACETAM; FLUOXETINE; FLUVOXAMINE; GALANTAMINE; HALOPERIDOL; LAMOTRIGINE; MEMANTINE; NALTREXONE; NEUROLEPTIC AGENT; OPIATE ANTAGONIST; PIMOZIDE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VITAMIN;

AGGRESSION; AGITATION; ALGORITHM; ANXIETY; ATTENTION DEFICIT DISORDER; AUTISM; AUTOMUTILATION; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNICATION DISORDER; CONSTIPATION; DEPRESSION; DRUG THERAPY; DYSKINESIA; FATIGUE; GASTROINTESTINAL DISEASE; HUMAN; HYPERACTIVITY; HYPOMANIA; IMMUNOPATHOLOGY; IMPULSIVENESS; INSOMNIA; IRRITABILITY; MEDICAL PRACTICE; MEDICAL SPECIALIST; MOVEMENT (PHYSIOLOGY); NEUROLOGY; OBSESSIVE COMPULSIVE DISORDER; OCCUPATIONAL THERAPY; REVIEW; SEDATION; SLEEP DISORDER; SPEECH THERAPY; TREATMENT PLANNING; WEIGHT GAIN;

AGGRESSION; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; COMMUNICATION DISORDERS; COMPLEMENTARY THERAPIES; DEPRESSIVE DISORDER; HUMANS; SELF-INJURIOUS BEHAVIOR; SLEEP DISORDERS; VITAMINS;

EID: 6344219780     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2004.07.007     Document Type: Review

References (89)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed text rev 1994 American Psychiatric Association Task Force on DSM-IV Washington, DC
2. R. Nass, O. Devinsky Autistic regression with rolandic spikes Neuropsychiatry Neuropsychol Behav Neurol 12 1999 193 197
3. J.D. Lewine, R. Andrews, M. Chez Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders Pediatrics 104 3 Pt 1 1999 405 418
4. L. Nobili, M.G. Baglietto, M. Beelke Modulation of sleep interictal epileptiform discharges in partial epilepsy of childhood Clin Neurophysiol 110 1999 839 845
5. L. Nobili, F. Ferrillo, M.G. Baglietto Relationship of sleep interictal epileptiform discharges to sigma activity (12-16 Hz) in benign epilepsy of childhood with rolandic spikes Clin Neurophysiol 110 1999 39 46
6. R. Tuchman, P. Jayakar, I. Yaylali Seizures and EEG findings in children with autism spectrum disorder CNS Spectrum 3 1998 61 68
7. R. Tuchman Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders J Autism Dev Disord 30 2000 485 489
8. T. Deonna Cognitive and behavioral disturbances as epileptic manifestations in children An overview Semin Pediatr Neurol 2 1995 254 260
9. E.R. Perez Syndromes of acquired epileptic aphasia and epilepsy with continuous spike-waves during sleep Models for prolonged cognitive impairment of epileptic origin Semin Pediatr Neurol 2 1995 269 277
10. M. Chez, C. Buchanan, M. Loeffel Practical treatment with pulse dose corticosteroids in pervasive developmental disorder or autistic patients with abnormal epileptiform sleep EEG and language delay M. Perat New Developments in Child Neurology 1998 Monduzzi Editore Bologna, Italy 695 698
11. A.V. Piloplys Autism Electroencephalogram abnormalities and clinical improvement with valproic acid Arch Pediatr Adolesc Med 148 1994 220 222
12. R. Bardenstein, M. Chez, B. Helfand Improvement in EEG and clinical function in pervasive developmental depay (PPD) Effect of valproic acid Annuals of Neurology 50 4 Suppl 1998 86 [abstract]
13. M.G. Chez, M.S. Hammer, M. Loeffel Clinical experience of three pediatric and one adult case of spike-and-wave status epilepticus treated with injectable valproic acid J Child Neurol 14 1999 239 242
14. G.A. Stefanatos, W. Grover, E. Geller Corticosteroid treatment of language regression in pervasive developmental disorder J Acad Child Adolesc Psychiatry 34 1995 1107 1111
15. E. Hollander, R. Dolgoff-Kaspar, C. Cartwright An open trial of divalproex sodium in autism spectrum disorders J Clin Psychiatry 62 2001 530 534
16. J.A. Childs, J.L. Blair Valproic acid treatment of epilepsy in autistic twins J Neurosci Nurs 29 1997 244 248
17. M. Chez, M. Loeffel, C. Buchanan Pulse high-dose steroids as combination therapy with valproic acid in epileptic aphasia patients with pervasive developmental delay or autism Ann Neurol 44 1998 53 59
18. T.H. Deonna, A.L. Ziegler, M.I. Maeder Reversible behavioural autistic-like regression: A manifestation of a special (new?) epileptic syndrome in a 28-month-old child. A 2-year longitudinal study Neurocase 1 1995 91 99
19. K.M. Belsito, P.A. Law, K.S. Kirk Lamotrigine therapy for autistic disorder A randomized, double-blind, placebo-controlled trial J Autism Dev Disord 31 2001 175 181
20. M.G. Chez, C.P. Buchanan, M.C. Aimonovitch Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders J Child Neurol 17 2002 833 837
21. E.K. Perry, M.L. Lee, C.M. Martin-Ruiz Cholinergic activity in autism Abnormalities in the cerebral cortex and basal forebrain Am J Psychiatry 158 2001 1058 1066
22. M.G. Chez, T. Buchanan, M. Becker Donezepil hydrochloride A double-blind study in autistic children J Pediatr Neurol 1 2003 83 88
23. A.Y. Hardan, B.L. Handen A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder J Child Adolesc Psychopharmacol 12 2002 237 241
24. M.G. Chez, M. Aimonovitch, T. Buchanan Treating autistic spectrum disorders in children Utility of the cholinesterase inhibitor rivastigmine tartrate J Child Neurol 19 2004 165 169
25. M. Hertzman Galantamine in the treatment of adult autism A report of three clinical cases Int J Psychiatry Med 33 2003 395 398
26. A.E. Purcell, O.H. Jeon, A.W. Zimmerman Postmortem brain abnormalities of the glutamate neurotransmitter system in autism Neurology 57 2001 1618 1628
27. M.G. Chez, P.C. Hung, K. Chin Memantine experience in children and adolescents with autistic spectrum disorders Ann Neurol 56 8 Suppl 2004 109 [abstract]
28. L.T. Anderson, M. Campbell, P. Adams The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children J Autism Dev Disord 19 1989 227 239
29. L.T. Anderson, M. Campbell, D.M. Grega Haloperidol in the treatment of infantile autism Effects on learning and behavioral symptoms Am J Psychiatry 141 1984 1195 1202
30. R. Perry, M. Campbell, P. Adams Long-term efficacy of haloperidol in autistic children Continuous versus discontinuous drug administration J Am Acad Child Adolesc Psychiatry 28 1989 87 92
31. R.R. Silva, R.P. Malone, L.T. Anderson Haloperidol withdrawal and weight changes in autistic children Psychopharmacol Bull 29 1993 287 291
32. J.J. Locascio, R.P. Malone, A.M. Small Factors related to haloperidol response and dyskinesias in autistic children Psychopharmacol Bull 27 1991 119 126
33. R.P. Malone, M. Ernst, K.A. Godfrey Repeated episodes of neuroleptic-related dyskinesias in autistic children Psychopharmacol Bull 27 1991 113 117
34. M. Ernst, H.J. Magee, N.M. Gonzalez Pimozide in autistic children Psychopharmacol Bull 28 1992 187 191
35. R.L. Findling, N.K. McNamara, L.A. Branicky A double-blind pilot study of risperidone in the treatment of conduct disorder J Am Acad Child Adolesc Psychiatry 39 2000 509 516
36. M. Nishimura, T. Hashimoto, M. Miyazaki An open trial of risperidone in autistic children No To Hattatsu 35 2003 473 477
37. L.E. Arnold, B. Vitiello, C. McDougle Parent-defined target symptoms respond to risperidone in RUPP autism study customer approach to clinical trials J Am Acad Child Adolesc Psychiatry 42 2003 1443 1450
38. V. Boon-Yasidhi, J. Tarugsa, C. Suwanwattana Risperidone in the treatment of autistic Thai children under 4 years of age J Med Assoc Thai 85 Suppl 2 2002 S784 S789
39. J.T. McCracken, J. McGough, B. Shah Research Units on Pediatric Psychopharmacology Autism Network Risperidone in children with autism and serious behavioral problems N Engl J Med 347 2002 314 321
40. A. Gagliano, E. Germano, G. Pustorino Risperidone treatment of children with autistic disorder effectiveness, tolerability, and pharmacokinetic implications J Child Adolesc Psychopharmacol 14 2004 39 47
41. A. Martin, L. Scahill, G.M. Anderson Weight and leptin changes among risperidone-treated youths with autism 6-month prospective data Am J Psychiatry 161 2004 1125 1127
42. D.C. Chugani Role of altered brain serotonin mechanisms in autism Mol Psychiatry 7 Suppl 2 2002 S16 S17
43. M. Alcami Pertejo, M. Peral Guerra, I. Gilaberte Open study of fluoxetine in children with autism Actas Esp Psiquiatr 28 2000 353 356
44. G.R. DeLong, L.A. Teague, M. McSwain Kamran Effects of fluoxetine treatment in young children with idiopathic autism Dev Med Child Neurol 40 1998 551 562
45. S.H. Fatemi, G.M. Realmuto, L. Khan Fluoxetine in treatment of adolescent patients with autism A longitudinal open trial J Autism Dev Disord 28 1998 303 307
46. E.H. Cook Jr, R. Rowlett, C. Jaselskis Fluoxetine treatment of children and adults with autistic disorder and mental retardation J Am Acad Child Adolesc Psychiatry 31 1992 739 745
47. G.R. DeLong, C.R. Ritch, S. Burch Fluoxetine response in children with autistic spectrum disorders correlation with familial major affective disorder and intellectual achievement Dev Med Child Neurol 44 2002 652 659
48. R.J. Steingard, B. Zimnitzky, D.R. DeMaso Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder J Child Adolesc Psychopharmacol 7 1997 9 15
49. J.A. Hellings, L.A. Kelley, W.F. Gabrielli Sertraline response in adults with mental retardation and autistic disorder J Clin Psychiatry 57 1996 333 336
50. C.J. McDougle, E.S. Brodkin, S.T. Naylor Sertraline in adults with pervasive developmental disorders A prospective open-label investigation J Clin Psychopharmacol 18 1998 62 66
51. T. Fukuda, H. Sugie, M. Ito Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder No To Hattatsu 33 2001 314 318
52. H. Yokoyama, M. Hirose, K. Haginoya Treatment with fluvoxamine against self-injury and aggressive behavior in autistic children No To Hattatsu 34 2002 249 253
53. W.L. Strauss, A.S. Unis, C. Cowan Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders Am J Psychiatry 159 2002 755 760
54. C.J. McDougle, L.E. Kresch, D.J. Posey Repetitive thoughts and behavior in pervasive developmental disorders Treatment with serotonin reuptake inhibitors J Autism Dev Disord 30 2000 427 435
55. C.A. Jaselskis, E.H. Cook Jr, K.E. Fletcher Clonidine treatment of hyperactive and impulsive children with autistic disorder J Clin Psychopharmacol 12 1992 322 327
56. M.P. Fankhauser, V.C. Karumanchi, M.L. German A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism J Clin Psychiatry 53 1992 77 82
57. H.M. Feldman, B.K. Kolmen, A.M. Gonzaga Naltrexone and communication skills in young children with autism J Am Acad Child Adolesc Psychiatry 38 1999 587 593
58. S.H. Willemsen-Swinkels, J.K. Buitelaar, H. van Engeland The effects of chronic naltrexone treatment in young autistic children A double-blind placebo-controlled crossover study Biol Psychiatry 39 1996 1023 1031
59. S.H. Willemsen-Swinkel, J.K. Buitelaar, G.J. Nijhof Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies Arch Gen Psychiatry 52 1995 766 773
60. S.H. Willemsen-Swinkels, J.K. Buitelaar, F.G. Weijnen Placebo-controlled acute dosage naltrexone study in young autistic children Psychiatry Res 16 1995 203 215
61. M. Campbell, L.T. Anderson, A.M. Small Naltrexone in autistic children Behavioral symptoms and attentional learning J Am Acad Child Adolesc Psychiatry 32 1993 1283 1291
62. G. Zingarelli, G. Ellman, A. Hom Clinical effects of naltrexone on autistic behavior Am J Ment Retard 97 1992 57 63
63. S.M. Cheer, K.L. Goa Fluoxetine A review of its therapeutic potential in the treatment of depression associated with physical illness Drugs 61 2001 81 110
64. R.J. Steingard, B. Zimnitzky, D.R. DeMaso Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder J Child Adolesc Psychopharmacol 7 1997 9 15
65. G.R. DeLong, L.A. Teague, M. McSwain Kamran Effects of fluoxetine treatment in young children with idiopathic autism Dev Med Child Neurol 40 1998 551 562
66. E.M. Mahone, D. Freeman, C. Prahme Clinical features of physiologic stereotypies in children Ann Neurol 54 2003 145
67. B.L. Handen, C.R. Johnson, M. Lubetsky Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder J Autism Dev Disord 30 2000 245 255
68. M.G. Aman, K.S. Langworthy Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders J Autism Dev Disord 30 2000 451 459
69. M.G. Chez, M. Becker, J. Keller Psychostimulant use in children with autistic spectrum disorder Ann Neurology 54 7 Suppl 2003 147 [abstract]
70. A.M. Connolly, M.D. Chez, B. Streif Antiendothelial autoantibodies Characterization of antigenic targets of sea from children with Landau-Kleffner syndrome, Landau-Kleffner variant, autism and epilepsy Ann Neurol 50 2001 S123
71. V.K. Singh, H.H. Fudenberg, D. Emerson Immunodiagnosis and immunotherapy in autistic children Ann N Y Acad Sci 540 1988 602 604
72. A.V. Plioplys, A. Greaves, K. Kazemi Immunoglobin reactivity in autism and Rett's syndrome Dev Brain Dys 7 1994 12 16
73. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine Immunization Safety Review Vaccines and Autism 2004 National Academy Press Washington, DC
74. S. Gupta Treatment of children with autism with intravenous immunoglobulin J Child Neurol 14 1999 203 205
75. A.V. Plioplys Intravenous immunoglobulin treatment in autism J Autism Dev Disord 30 2000 73 74
76. D. Posey A pilot study of D-cycloserine in autistic disorder. Presented at the 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry 2003
77. R.H. Sandler, S.M. Finegold, E.R. Bolte Short-term benefit from oral vancomycin treatment of regressive-onset autism J Child Neurol 15 2000 429 435
78. D.A. Trauner, C. Nabangchang, A. Ballantyne Developmental aphasia with epileptiform abnormalities on EEG Clinical features and response to prednisone Am Neurology 52 3 Suppl 2002 66 67 [abstract]
79. J.K. Buitelaar, H. van Engeland, K.H. de Kogel The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children effects on the organization of behavior Biol Psychiatry 31 1992 1119 1129
80. J.K. Buitelaar, H. van Engeland, K. de Kogel The adrenocorticotrophic hormone (4-9) analog ORG 2766 benefits autistic children Report on a second controlled clinical trial J Am Acad Child Adolesc Psychiatry 31 1992 1149 1156
81. K. Horvath, J.A. Perman Autism and gastrointestinal symptoms Curr Gastroenterol Rep 4 2002 251 258
82. A.D. Sandler, J.W. Bodfish Placebo effects in autism lessons from secretin J Dev Behav Pediatr 21 2000 347 350
83. M.G. Chez, C.P. Buchanan, B.T. Bagan Secretin and autism A two-part clinical investigation J Autism Dev Disord 30 2000 87 94
84. J. Dunn-Geier, H.H. Ho, E. Auersperg Effect of secretin on children with autism A randomized controlled trial Dev Med Child Neurol 42 2000 796 802
85. E. Sponheim, G. Oftedal, S.B. Helverschou Multiple doses of secretin in the treatment of autism A controlled study Acta Paediatr 91 2002 540 545
86. A.S. Unis, J.A. Munson, S.J. Rogers A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism J Am Acad Child Adolesc Psychiatry 41 2002 1315 1321
87. G.L. Arnold, S.L. Hyman, R.A. Mooney Plasma amino acids profiles in children with autism Potential risk of nutritional deficiencies J Autism Dev Disord 33 2003 449 454
88. E. Sponheim Gluten-free diet in infantile autism A therapeutic trial Tidsskr Nor Laegeforen 111 1991 704 707
89. E. Cornish Gluten and casein free diets in autism A study of the effects on food choice and nutrition J Hum Nutr Diet 15 2002 261 269